Majed Jeroudi
Pediatric Hematology-Oncology · Shreveport, LANPI 1154348050
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Novartis at 28.3% of the total. Reporting peaked in 2023 at $675 and has fallen 62.5% since, to $253 in 2025.
Across 78 payments — averaging $23.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$522
- Pfizer$299
- Fennec Pharmaceuticals, Inc.$215
- CSL Behring$183
- Emmaus Medical, Inc.$153
- Global Blood Therapeutics, Inc.$123
- plus $351 from 13 others
What the payments were for
- Food & beverage$1,847100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 30 | $522 |
| Pfizer | 8 | $299 |
| Fennec Pharmaceuticals, Inc. | 3 | $215 |
| CSL Behring | 4 | $183 |
| Emmaus Medical, Inc. | 8 | $153 |
| Global Blood Therapeutics, Inc. | 8 | $123 |
| Agios Pharmaceuticals, Inc. | 1 | $54 |
| Servier Pharmaceuticals LLC | 3 | $47 |
| Bayer | 2 | $46 |
| Novo Nordisk | 2 | $34 |
| Chiesi USA, Inc. | 1 | $31 |
| Sobi, Inc | 1 | $23 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $22 |
| Duchesnay USA Incorporated | 1 | $18 |
| Amgen | 1 | $17 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
| Grifols USA, LLC | 1 | $16 |
| Medexus Pharma, Inc. | 1 | $14 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,847 in reported general payments places this provider in the 55th percentile of 26 pediatric hematology-oncology providers in Louisiana.
See all pediatric hematology-oncology providers in Louisiana →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxyurea | 12 | $235 |
| Ondansetron OdtOndansetron | 15 | $108 |
Paid to pharmacies, not to this prescriber.
Other pediatric hematology-oncology in Shreveport
- Ayobami OlanrewajuShreveport$937
- Alejandra Rosales HernandezShreveport$361
- Nidal MahgoubShreveport$73
- Tammuella Chrisentery-SingletonNew Orleans$1.4M
- Maria Velez-YanguasNew Orleans$105K
- Corey FalconMetairie$104K
- Zachary LeblancNew Orleans$55K
- Dana LeblancNew Orleans$25K
- Renee GardnerNew Orleans$25K
- Pinki PrasadNew Orleans$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.